Global Pharmaceuticals & Biotech Big Green Snowflakes

Everest Organics

Market Cap: ₹4.0b

Engages in the manufacture and sale of active pharmaceutical ingredients and its intermediaries in India.

Sinew Pharma

Market Cap: NT$3.3b

A biopharmaceutical company, focuses on the development and sale of drugs for the treatment of hepatotoxicity-free acetaminophen and fatty liver diseases.

ShanXi C&Y Pharmaceutical GroupLTD

Market Cap: CN¥2.7b

Engages in the research, development, production, and sale of medicine and health food products.

Pell Bio-Med Technology

Market Cap: NT$25.4b

A biomedical company, engages in the development of cell culture technologies and techniques for therapeutic applications.

GENINUS

Market Cap: ₩66.7b

A bioinformation analysis company, engages in the research and development, manufacture, and sale of next generation sequencing (NGS) - based genome analysis solutions in South Korea.

Shree Ganesh Remedies

Market Cap: ₹7.4b

Engages in the manufacture and sale of pharmaceutical drug intermediates for active pharmaceutical ingredient (API) and fine chemicals in India and internationally.

Blue Wave Water Capital

Market Cap: ₪9.0m

Engages in the multiplication, cultivation, production, and sale of cannabis for medical purposes.

Kyongbo Pharmaceutical

Market Cap: ₩130.1b

Manufactures and sells active pharmaceutical ingredients and finished drugs in South Korea and internationally.

Guangdong Hybribio BiotechLtd

Market Cap: CN¥3.7b

Engages in the research and development, manufacture, and sale of nucleic acid molecular diagnostic products for hospitals and medical institutes.

ImmuneOncia Therapeutics

Market Cap: ₩425.0b

An immuno-oncology-centric biopharmaceutical company, develops immuno-oncology drugs for the treatment of cancer.

Zhejiang Wecome Pharmaceutical

Market Cap: CN¥3.1b

Engages in the research and development, production, and sale of modern traditional Chinese and western medicine in China.

RaQualia Pharma

Market Cap: JP¥14.1b

Engages in the research and development of pharmaceutical compounds worldwide.

LIDDS

Market Cap: SEK 10.1m

A drug delivery company, develops pharmaceutical products based on its NanoZolid proprietary technology for the treatment of cancer and other diseases in Sweden.

Orexo

Market Cap: SEK 851.3m

A specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally.

Hamlet BioPharma

Market Cap: SEK 746.3m

Engages in the development of drugs for the treatment and prevention of cancer in Sweden.

AquaBounty Technologies

Market Cap: US$4.6m

Operates as a land-based aquaculture company in the United States.

ETHZilla

Market Cap: US$401.2m

A clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases in the United States.

Onco-Innovations

Market Cap: CA$100.4m

A pre-clinical stage biotechnology company, develops drug candidates for cancer treatments.

Kodiak Sciences

Market Cap: US$530.2m

A clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases.

EGF Theramed Health

Market Cap: CA$929.3k

Engages in the development of psychedelic drugs for the treatment of mental health problems in Canada.

Elicio Therapeutics

Market Cap: US$189.7m

A clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer.

Adaptive Biotechnologies

Market Cap: US$1.9b

A commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.

ABVC BioPharma

Market Cap: US$62.7m

A clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States.

Panacea Life Sciences Holdings

Market Cap: US$2.2m

Operates as a holding company, researchers, develops, manufactures, produces, and distributes cannabinoids, mushrooms, kratom, and other natural, plant-based ingredients and products for humans and animals.

AIM ImmunoTech

Market Cap: US$6.8m

An immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States.

Anbio Biotechnology

Market Cap: US$2.0b

Provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally.

Quest PharmaTech

Market Cap: CA$5.9m

A pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer.

Nuo Therapeutics

Market Cap: US$87.0m

Operates as a regenerative therapies company that develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States.

Genome

Market Cap: ₩87.0b

A clinical stage biotechnology company, researches and develops novel-targeted immuno-oncology therapeutics in the field of immuno-oncology, skin diseases, and autism in South Korea.

PhoenixBio

Market Cap: JP¥1.8b

Provides contract study services for drug discovery and development primarily in Japan.

CHO Pharma

Market Cap: NT$8.1b

Engages in research and development of biotechnology in Taiwan.

Psomagen

Market Cap: ₩73.5b

Engages in the provision omics solutions and contract laboratory services.

BioDlink International

Market Cap: HK$1.7b

An investment holding company, engages in the research and development, manufacturing, and marketing of anti-tumor drugs in Mainland China and internationally.

WooGene B&G

Market Cap: ₩27.6b

Engages veterinary medicines, microbial technology, and vaccines business in South Korea and internationally.

Formosa Pharmaceuticals

Market Cap: NT$4.6b

A clinical stage biopharmaceutical company, engages in developing drug candidates for ophthalmology, oncology, and anti-infectives in Taiwan.

Gansu Longshenrongfa Pharmaceutical IndustryLTD

Market Cap: CN¥3.1b

Researches, develops, produces, and sells Chinese patent medicines, health food, and APIs in China and internationally.